Transforming growth factor-β and epithelial-mesenchymal transition are associated with pulmonary metastasis in adenoid cystic carcinoma

Oral Oncology

Volumn 49, Issue 11, 2013, Pages 1051-1058

  Dong, Ling ^a   Ge, Xi Yuan ^a   Wang, Yi Xiang ^a   Yang, Lin Qian ^a   Li, Sheng Lin ^a   Yu, Guang Yan ^a   Gao, Yan ^a   Fu, Jia ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Adenoid cystic carcinoma; Epithelial mesenchymal transition; Gene therapy; Pulmonary metastasis; Transforming growth factor 1

Indexed keywords

BETA CATENIN; NECTIN 1; SMAD2 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA; UVOMORULIN;

ADENOID CYSTIC CARCINOMA; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CELL MEMBRANE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; LUNG PARENCHYMA; MALE; MORPHOLOGICAL TRAIT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SPINDLE CELL; WESTERN BLOTTING;

ACC; ADENOID CYSTIC CARCINOMA; CA(2+)-INDEPENDENT IMMUNOGLOBULIN-LIKE CELL ADHESION MOLECULES; CAMS; EMT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE THERAPY; H-SCORE; IMMUNOHISTOCHEMICAL SCORE; MEMBRANE EXPRESSION OF Β-CATENIN; P-SMAD2; PHOSPHO-SMAD2; PULMONARY METASTASIS; RECEIVER OPERATING CHARACTERISTIC; ROC; TGF-Β1; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR-Β1; Β-CATENIN RM;

ANIMALS; BETA CATENIN; CADHERINS; CARCINOMA, ADENOID CYSTIC; CELL ADHESION MOLECULES; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASMS, EXPERIMENTAL; REAL-TIME POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS; SMAD2 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

EID: 84888639320     PISSN: 13688375     EISSN: 18790593     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2013.07.012     Document Type: Article

References (24)

1. Spiro RH. Salivary neoplasms: overview of a 35-year experience with 2,807 patients. Head Neck Surg 1986;8(3):177-84.
2. Matsuba HM, Simpson JR, Mauney M, et al. Adenoid cystic salivary gland carcinoma: a clinicopathologic correlation. Head Neck Surg 1986;8(3):200-4.
3. Ciccolallo L, Licitra L, Cantu G, et al. Survival from salivary glands adenoid cystic carcinoma in European populations. Oral Oncol 2009;45(8):669-74.
4. He JF, Ge MH, Zhu X, et al. Expression of RUNX3 in salivary adenoid cystic carcinoma: implications for tumor progression and prognosis. Cancer Sci 2008;99(7):1334-40.
5. Muller A, Sonkoly E, Eulert C, et al. Chemokine receptors in head and neck cancer: association with metastatic spread and regulation during chemotherapy. Int J Cancer 2006;118(9):2147-57.
6. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature 2003;425(9):577-84.
7. Wendt MK, Tian M, Schiemann W.P. Deconstructing the mechanisms and consequences of TGF-beta-induced EMT during cancer progression. Cell Tissue Res 2012;347(1):85-101.
8. Dong L, Wang YX, Li SL, et al. TGF-beta1 promotes migration and invasion of salivary adenoid cystic carcinoma. J Dent Res 2011;90(6):804-9.
9. Du F, Nakamura Y, Tan TL, et al. Expression of snail in epidermal keratinocytes promotes cutaneous inflammation and hyperplasia conducive to tumor formation. Cancer Res 2010;70(24):10080-9.
10. Brembeck FH, Rosário M, Birchmeier W. Balancing cell adhesion and Wnt signalin, the key role of β-catenin. Curr Opin Genet Dev 2006;16(1):51-9.
11. Huang AH, Pettigrew NM, Watson PH. Immunohistochemical assay for oestrogen receptors in paraffin wax sections of breast carcinoma using a new monoclonal antibody. J Pathol 1996;180(1):223-7.
12. Li SL, Liu XP, Zhang KH. Establishment of a human cancer cell line from adenoid cystic carcinoma of the minor salivary gland. Chin J Stomatol 1990;25:29-31.
13. Kokemueller H, Eckardt A, Brachvogel P, et al. Adenoid cystic carcinoma of the head and neck - a 20 years experience. Int J Oral Maxillofac 2004;33(1):25-31.
14. McEarchern JA, Kobie JJ, Mack V, et al. Invasion and metastasis of a mammary tumor involves TGF-beta signaling. Int J Cancer 2001;91(1):76-82.
15. Tang B, Vu M, Booker T, et al. TGF-beta switches from tumor suppressor to prometastatic factor in a model of breast cancer progression. J Clin Invest 2003;112(7):1116-24.
16. Janda E, Lehmann K, Killisch I, et al. Ras and TGF-beta cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. J Cell Biol 2002;156(2):299-313.
17. Oft M, Akhurst RJ, Balmain A. Metastasis is driven by sequential elevation of Hras and Smad2 levels. Nat Cell Biol 2002;4(7):487-94.
18. Tian F, Byfield SD, Parks WT, et al. Reduction in Smad2/3 signaling enhances tumorigenesis but suppresses metastasis of breast cancer cell lines. Cancer Res 2003;63(23):8284-92.
19. Knust E, Bossinger O. Composition and formation of intercellular junctions in epithelial cells. Science 2002;298(5600):1955-9.
20. Birchmeier W, Hulsken J, Behrens J. E-Cadherin as an invasion suppressor. Ciba Found Symp 1995;189:124-41. discussion 136-41, 174-6.
21. Tian YC, Phillips AO. Interaction between the transforming growth factor-beta type II receptor/Smad pathway and beta-catenin during transforming growth factor-beta 1-mediated adherens junction disassembly. Am J Pathol 2002;160(5):1619-28.
22. Furuse C, Cury PR, Altemani A, et al. Beta-catenin and E-cadherin expression in salivary gland tumors. Int J Surg Pathol 2006;14(3):212-7.
23. Tang YL, Liang XH, Zheng M, et al. Expression of c-kit and Slug correlates with invasion and metastasis of salivary adenoid cystic carcinoma. Oral Oncol 2010;46(4):311-6.
24. Takai Y, Shimizu K, Ohtsuka T. The roles of cadherins and nectins in interneuronal synapse formation. Curr Opin Neurobiol 2003;13(5):520-6.